Nemolizumab (CIM331) is a humanized monoclonal antibody against human interleukin-31 receptor A that inhibits the binding and subsequent signal transduction of interleukin-31 (IL-31) to its receptor. Nemolizumab can be used to study atopic dermatitis wit
CAS Number:
[1476039-58-3]
Target:
Interleukin
* VAT and and shipping costs not included. Errors and price changes excepted